Cone beam computed tomography (CBCT) image guidance has become more widely used for spine radiosurgery delivery.Our center began a dedicated spine radiosurgery program that utilizes CBCT image guidance technology for target localization. This study prospectively evaluated the spinal cord and cauda equina doses received during single fraction spine radiosurgery treatments in order to determine a safety profile for this technique. Two hundred consecutive spine and paraspinal lesions were treated using the Elekta Synergy S 6-MV linear accelerator with a beam modulator and CBCT image guidance combined with a HexaPOD couch that allows patient positioning correction in 3 translational and 3 rotational directions. Lesion location included 33 cervical, 84 thoracic, 60 lumbar, and 23 sacral tumors. Tumor histologies included 164 malignant and 36 benign. One hundred thirty-three lesions (66%) had received prior conventional fractionated radiotherapy. Thirty-three lesions (16%) were intradural. Radiosurgery was used as a primary treatment modality in 60 cases (30%), for radiographic progression after prior conventional radiotherapy in 96 cases (48%), and adjuvant post-surgery therapy in 44 cases (22%). For each case, the maximum point dose to the spinal cord and/or cauda equina as well as the volume of those organs at risk receiving greater than 8, 10, and 12 Gy were recorded. No subacute or long term spinal cord or cauda equina toxicity occurred during the follow-up period (median 21 months). For cases at the level of the spinal cord (117 cases) the mean prescribed dose to the gross tumor volume (GTV) was 14 Gy (range 11-18 Gy). The GTV ranged from 0.37 to 100.24 cm (mean 26.1 cm). The mean maximum point dose to the spinal cord was 10 Gy (range 4-12 Gy), and the mean spinal cord volumes (cm) receiving greater than 8, 10, and 12 Gy were 0.76 (0-3.45), 0.05 (0-.42), and 0.0, respectively. For cases at the level of the cauda equina (83 cases) the mean prescribed dose to the GTV was 15 Gy (range 10-20 Gy). The GTV ranged from 0.19 to 491.6 cm (mean 73.8 cm). The mean maximum point dose to the cauda equina was 11 Gy (range 5-14 Gy), and the mean cauda equina volumes (cm) receiving greater than 8, 10, and 12 Gy were 1.4 (0-6.68), 0.26 (0-2.99), and 0.02 (0-.39), respectively. This study demonstrates that limiting the spinal cord dose to 10 Gy and the cauda equina dose to 11 Gy can be achieved with therapeutic GTV prescription doses for single fraction spine radiosurgery using CBCT guidance. Such dose constraints are associated with a safe clinical outcome.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725316 | PMC |
Naunyn Schmiedebergs Arch Pharmacol
January 2025
The Key Laboratory of Spine and Spinal Cord Disease of Jiangxi Province, Nanchang, 330006, China.
Chrysoeriol (CHE) is a naturally occurring compound with established anti-inflammatory and anti-tumor effects. This study examines its potential role in regulating osteoclast differentiation and activity, both of which are crucial for bone remodeling. Computational docking revealed high binding affinity between CHE and RANKL, specifically at the Lys-181 residue of RANKL, suggesting potential inhibitory interactions on osteoclastogenesis.
View Article and Find Full Text PDFActa Neuropathol Commun
January 2025
Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College (PUMC) and Chinese Academy of Medical Science (CAMS), Beijing, China.
Mutations in the ANXA11 gene, encoding an RNA-binding protein, have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), but the underlying in vivo mechanisms remain unclear. This study examines the clinical features of ALS patients harboring the ANXA11 hotspot mutation p.P36R, characterized by late-onset motor neuron disease and occasional multi-system involvement.
View Article and Find Full Text PDFBMC Med Educ
January 2025
Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Introduction: Ultrasound is important in heart diagnostics, yet implementing effective cardiac ultrasound requires training. While current strategies incorporate digital learning and ultrasound simulators, the effectiveness of these simulators for learning remains uncertain. This study evaluates the effectiveness of simulator-based versus human-based training in Focused Assessed with Transthoracic Echocardiography (FATE).
View Article and Find Full Text PDFBMC Neurol
January 2025
Faculty of Medicine, Department of Neurology, Al-Quds University, Jerusalem, Palestine.
Background: Vanishing white matter disease (VWMD) is a rare autosomal recessive leukoencephalopathy. It is typified by a gradual loss of white matter in the brain and spinal cord, which results in impairments in vision and hearing, cerebellar ataxia, muscular weakness, stiffness, seizures, and dysarthria cogitative decline. Many reports involve minors.
View Article and Find Full Text PDFJ Pediatr Urol
January 2025
Department of Women and Children's Health, School of Life Course Sciences, Kings College London, London, UK; Children's Bladder Service, Evelina London Children's Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Introduction: The Mirabegron-anticholinergic (MAC) combination has proven effective as a step-up strategy in managing paediatric neurogenic bladder following anticholinergic medication and botulinum toxin (BTX) therapy. This study assesses the long-term efficacy of MAC in children with neurogenic bladder.
Patients And Methods: A retrospective chart review was conducted from 2015 to 2023, including consecutive paediatric patients receiving Mirabegron (25/50 mg) with an anticholinergic agent (solifenacin 16, tolterodine 7, oxybutynin 7, trospium 1).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!